Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FCER1G |
| Upstream (Parents) |
|---|
| (<<) CD53 → FCER1G |
| (<<) TYROBP → FCER1G |
| (<<) CD86 → FCER1G |
| Downstream (Children) |
|---|
| FCER1G → CD53 (>>) |
| FCER1G → EMP3 (>>) |
| FCER1G → AP1S2 (>>) |
| FCER1G → EIF4A1///CD68 (>>) |
| FCER1G → LILRB1 (>>) |
| FCER1G → DPEP2 (>>) |
| FCER1G → CD33 (>>) |
| FCER1G → STK32B (>>) |
| FCER1G → PTAFR (>>) |
| FCER1G → PRKCA (>>) |
| FCER1G → SPI1 (>>) |
| FCER1G → BTG3 (>>) |
| FCER1G → LY96 (>>) |
| FCER1G → PLTP (>>) |
| FCER1G → LILRA6///LILRB3 (>>) |
| FCER1G → NCKAP1L (>>) |
| FCER1G → HCLS1 (>>) |
| FCER1G → TYROBP (>>) |
| FCER1G → TLR2 (>>) |
